ArticleTransplant infectious disease : an official journal of the Transplantation Society2022

Outcomes of bebtelovimab and sotrovimab treatment of solid organ transplant recipients with mild-to-moderate coronavirus disease 2019 during the Omicron epoch.

Zachary A Yetmar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.